Summary & Overview
CPT 59072: Selective Fetal Reduction for Twin–to–Twin Transfusion Syndrome
CPT code 59072 denotes a selective fetal reduction procedure performed for advanced twin–to–twin transfusion syndrome, using a transabdominal approach with ultrasound guidance to terminate a nonviable co-twin and preserve the surviving fetus. This code is relevant nationally because it documents a high-acuity, specialized obstetric intervention with implications for hospital resource use, surgical credentialing, and payer coverage policies.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and service setting, common billing modifiers and coding considerations, and the typical site-of-service implications that affect coverage and claims processing. The publication summarizes benchmark elements readers should expect when reviewing payer policies and outlines where clinical documentation and operative detail matter for claims adjudication.
This analysis provides a concise reference for billing staff, clinical coders, and policy analysts to understand the procedural intent, appropriate reporting of the service, and the operational context in which 59072 is used. Data not available in the input are noted where applicable, and readers will gain clarity on the clinical scenario captured by this CPT code without state-specific guidance.
Billing Code Overview
CPT code 59072 describes a targeted fetal procedure performed for advanced twin–to–twin transfusion syndrome to terminate the nonviable co-twin and maximize survival of the coexisting normal fetus. The procedure is performed via a transabdominal approach with ultrasound guidance, and the clinical intent is selective fetal reduction in the setting of severe monochorionic twin complications.
Service type: Surgical fetal intervention / selective fetal reduction
Typical site of service: Hospital operating room or specialized fetal surgery suite, with ultrasound guidance in an inpatient or procedural setting.
Clinical & Coding Specifications
Clinical Context
A 30-year-old gravida 2 para 1 patient at 20 weeks gestation with monochorionic diamniotic twins presents with progressive discordant growth and ultrasound findings consistent with advanced twin–to–twin transfusion syndrome (TTTS) Stage III–V. One twin demonstrates severe hydrops and absent or reversed end-diastolic flow, while the co-twin shows relatively preserved cardiac function. After multidisciplinary counseling with maternal–fetal medicine, neonatology, and ethics, the care team and family elect selective fetal reduction of the nonviable twin to maximize survival and outcomes for the coexisting fetus.
The procedure is performed in an outpatient or ambulatory surgery setting or inpatient antepartum unit equipped with ultrasound and fetal monitoring. Under continuous ultrasound guidance and sterile technique, the provider accesses the affected twin via a transabdominal approach and performs intracardiac potassium chloride injection (feticide) to terminate the nonviable twin, followed by observation of fetal cardiac standstill and postprocedure monitoring of maternal vital signs and fetal heart tracing for the surviving twin. Relevant documentation includes informed consent, indication (advanced TTTS), gestational age, ultrasound images and measurements, procedure description (transabdominal approach, ultrasound guidance, agent used), anesthesia type, complications if any, and postprocedure instructions and follow-up plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Original procedure performed |